KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. Leading Sponsorship at Annual EPOS Meeting

OrthoPediatrics Corp. Leading Sponsorship at Annual EPOS Meeting

WARSAW, Ind., March 31, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced its leading sponsorship at the European Pediatric Orthopaedic Society (“EPOS”) annual meeting in Krakow, Poland. The company hosted an exhibit for OrthoPediatrics, Pega Medical, and MD Orthopaedics as well as a surgeon luncheon.

OrthoPediatrics’ President & CEO, David Bailey, commented, “We are excited to be in Poland with our surgeon customers from all over Europe. This meeting represents another great educational moment for pediatric orthopedic surgeons around the world. This year, we are united together as one company with Pega Medical and MD Orthopaedics, all focused on the shared cause of helping KIDS!”

At the meeting, OrthoPediatrics sponsored a surgeon luncheon, Osteogenesis Imperfecta – case presentations: surgical dilemmas. Presenters Dr. Markek Jozwiak (Poznan, Poland) and Dr. Nicolas Nicolaou (Sheffield, UK) discussed the topic as moderated by Dr. Scott Hoffinger, Medical Director of OrthoPediatrics. Osteogenesis imperfecta (“OI”) is one of the most challenging surgical problems pediatric orthopedics faces. The presentation highlighted case studies and engaged EPOS attendees in discussion of their experiences and best practices. Topics discussed included: what age to begin, how many bones at one time, perioperative bisphosphonate therapy, when to exchange rods, when to go non-expandable, and more.

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 47 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit .

Investor Contact

Philip Trip Taylor

Gilmartin Group



415-937-5406



EN
31/03/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue...

OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance Company to host conference call today, October 9th, 2025, to discuss the financial results and updated outlook WARSAW, Ind., Oct. 09, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the third quarter ended September 30, 2025, and revised 2025 financial guidance. Preliminary Third Quarter 2025 Results...

 PRESS RELEASE

OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spin...

OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the VerteGlide Spinal Growth Guidance System (“VerteGlide”), used to treat Early Onset Scoliosis (“EOS”). Dr. Richard McCarthy, a pediatric orthopedic spine surgeon in Louisville, Kentucky who, along with Dr. Kent Wa...

 PRESS RELEASE

OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.

OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc. Advancing Care for Pediatric Trauma Patients WARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries. This collaboration will expand access to MY01’s Continuous Perfusion Sensing Technology™ (CPST™) Platform for children and adolescents, a population...

 PRESS RELEASE

OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to it...

OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025. “We’re excited to ...

 PRESS RELEASE

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results an...

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance Second Quarter 2025 Revenue Surpasses $60 million for the First Time in Company History, and Increased Adjusted EBITDA by 58% year-over-year WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 and Business Highlights       He...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch